Cerebral Protection in Transcatheter Aortic Valve Replacement
Public ClinicalTrials.gov record NCT02214277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cerebral Protection in Transcatheter Aortic Valve Replacement - The SENTINEL Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Sentinel System will be a safe and effective method for capturing and removing embolic material (thrombus/debris) during transcatheter aortic valve replacement in order to reduce the ischemic burden in the cerebral anterior circulation.
Study identification
- NCT ID
- NCT02214277
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 363 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2014 (Type not available)
- Primary completion
- Mar 2016 (Actual)
- Completion
- Jun 2016 (Actual)
- Last update posted
- May 11, 2018
2014 – 2016
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | — | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | — | — |
| Morton Plant Hospital | Clearwater | Florida | — | — |
| Emory University Hospital | Atlanta | Georgia | — | — |
| Henry Ford Hospital | Detroit | Michigan | — | — |
| Barnes-Jewish Hospital | St Louis | Missouri | — | — |
| Columbia University Medical Center | New York | New York | — | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | — | — |
| Weill Cornell Medical Center | New York | New York | — | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | — | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | — | — |
| UT Houston / Memorial Hermann | Houston | Texas | — | — |
| UVA Advanced Cardiac Valve Center | Charlottesville | Virginia | — | — |
| UW Medical Center | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02214277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02214277 live on ClinicalTrials.gov.